|
|
6120 Paseo Del Norte Ste. B2
Carlsbad, CA 92009-1331 USA
phone:(760) 603-8989
fax:(760) 603-8558
|
|
| Symbol |
Private |
| Founded |
0 |
| Employees |
|
|
|
| www.medinox.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Small molecule drugs to treat sepsis, arthritis & inflammation, diabetes and sickle cell anemia.
|
|
| Management |
| Ching-San (Monte) Lai, Ph.D., President & CEO; George Gill, M.D., Sr. Vice President, Clinical Development; F. David King, Vice President, Corporate Development |
| |
|
|
| |
|
| Keywords |
| small molecule drugs, sepsis, arthritis, inflammation, Diabetes, blood sugar, diabetic, metabolic, insulin, sickle cell anemia, nitric oxide |
|
|
|
| Description |
|
Medinox, Inc. develops small molecule drugs to treat sepsis, arthritis & inflammation, diabetes and sickle cell anemia.
|
|
| Technology / Differentiation |
| The Company's research and clinical development programs fall into two broad categories: 1) nitric oxide neutralizers, and 2) novel prodrugs. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members